New imaging test for invasive lobular breast cancer that has spread
Part of Cancer, Skin clinical trials.
This trial tests a new imaging agent, [68Ga]Ga DOTA-5G, to see if it can better detect invasive lobular breast cancer that has spread to other parts of the body. It involves a PET/CT scan and may help doctors understand the extent of your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been diagnosed with invasive lobular breast cancer that has spread to other parts of your body (stage IV).
- You can provide a sample of your tumor from a previous biopsy or surgery.
- You are able to lie still for up to 60 minutes for the scan.
- Your blood counts and kidney/liver function are within certain levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging scan and a targeted radiation treatment for certain cancers that have spread. First, a special PET scan finds tumors that light up; then, if eligible, you may receive a treatment that targets those same tumors.
This trial tests a new targeted radioactive drug that seeks out a specific marker on lung cancer cells. It first uses a low-dose imaging scan to see if the cancer cells have this marker, then gives a higher-dose treatment to destroy those cells.
This trial tests a new type of PET/CT scan (using a tracer called FAPI-46) to find cancer spread in people with lobular breast cancer. It may be an option if your standard scan was unclear or negative.
This trial tests a special PET scan (F-FAPI PET) to image metastatic invasive lobular breast cancer. It aims to see if this scan gives a clearer picture than the standard PET scan, helping doctors track the cancer better.
This study examines how different imaging scans and blood tests can help doctors better understand the extent of stage IV (advanced) lobular breast cancer. If you have this type of cancer and are starting your first treatment, this trial may help improve how doctors detect and monitor your disease.
This trial studies whether a specific PET/CT scan using Ga-68 IAC helps diagnose and guide treatment decisions in people with metastatic breast cancer. It also focuses on whether the scan is safe and helpful for clinical management.
Hear when a new Metastatic Lobular Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.